SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-09-004807
Filing Date
2009-12-07
Accepted
2009-12-07 17:29:29
Documents
6
Period of Report
2009-12-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_35409.htm 8-K 26852
2 EX-2.1 exhibit1.htm EX-2.1 280778
3 EX-10.1 exhibit2.htm EX-10.1 21675
4 EX-10.2 exhibit3.htm EX-10.2 21099
5 EX-10.3 exhibit4.htm EX-10.3 41879
6 EX-99.1 exhibit5.htm EX-99.1 13327
  Complete submission text file 0001299933-09-004807.txt   407363
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 091226887
SIC: 2836 Biological Products, (No Diagnostic Substances)